Literature DB >> 11154091

Dystonia update.

S B Bressman1.   

Abstract

Dystonia is a syndrome of sustained muscle spasms of presumed central nervous system origin. Recent advances in molecular biology have permitted clearer understanding of the genetics of various forms of dystonia and suggest pathophysiological deficits at the origin of the clinical signs. Treatment has involved centrally-acting drugs, specifically the anticholinergic medications, as well as peripherally acting agents that block neuromuscular transmission (botulinum toxin). Some forms of dystonia are particularly responsive to levodopa. A systematic approach to the diagnostic and treatment evaluation of dystonic patients permits optimal care for long-term management.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154091     DOI: 10.1097/00002826-200009000-00002

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  14 in total

1.  Microstructural white matter changes in primary torsion dystonia.

Authors:  Maren Carbon; Peter B Kingsley; Chengke Tang; Susan Bressman; David Eidelberg
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

Review 2.  Diagnosis of dystonic syndromes--a new eight-question approach.

Authors:  Kelly L Bertram; David R Williams
Journal:  Nat Rev Neurol       Date:  2012-03-20       Impact factor: 42.937

3.  Primary dystonia misinterpreted as Parkinson disease: Video case presentation and practical clues.

Authors:  Olga Klepitskaya; Alexander J Neuwelt; Tam Nguyen; Maureen Leehey
Journal:  Neurol Clin Pract       Date:  2013-12

4.  Modulation of the basal ganglia dopaminergic system in a transgenic mouse exhibiting dystonia-like features.

Authors:  Dimitra Giannakopoulou; Ioanna Armata; Ada Mitsacos; Pullani Shashidharan; Panagiotis Giompres
Journal:  J Neural Transm (Vienna)       Date:  2010-12-07       Impact factor: 3.575

Review 5.  Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management.

Authors:  Svenja Happe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 6.  Primary blepharospasm: diagnosis and management.

Authors:  Giovanni Defazio; Paolo Livrea
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Deep Brain Stimulation for Dystonia.

Authors:  William J Marks
Journal:  Curr Treat Options Neurol       Date:  2005-05       Impact factor: 3.972

8.  Botulinum toxin type A in the treatment of patients with cervical dystonia.

Authors:  Allison Brashear
Journal:  Biologics       Date:  2009-07-13

Review 9.  Convergent evidence for abnormal striatal synaptic plasticity in dystonia.

Authors:  David A Peterson; Terrence J Sejnowski; Howard Poizner
Journal:  Neurobiol Dis       Date:  2009-12-18       Impact factor: 5.996

10.  The Frequency of DYT1 (GAG Deletion) Mutation in Primary Dystonia Patients from Iran.

Authors:  Mohammad Hamid; Mohammad Taghi Akbari; Gholam Ali Shahidi; Zahra Zand
Journal:  Cell J       Date:  2011-04-21       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.